About
Technology
Issues
FAQ
Links
Official Page
Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.